DUBA: A deubiquitinase that regulates type I interferon production

被引:382
作者
Kayagaki, Nobuhiko
Phung, Qui
Chan, Salina
Chaudhari, Ruchir
Quan, Casey
O'Rourke, Karen M.
Eby, Michael
Pietras, Eric
Cheng, Genhong
Bazan, J. Fernando
Zhang, Zemin
Arnott, David
Dixit, Vishva M. [1 ]
机构
[1] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
[3] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA
[4] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[5] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA
关键词
D O I
10.1126/science.1145918
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A ( DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA-based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor-associated factor 3 ( TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63-linked polyubiquitin chains. DUBA selectively cleaved the lysine-63-linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANKbinding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.
引用
收藏
页码:1628 / 1632
页数:5
相关论文
共 26 条
[1]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]   Identification of the familial cylindromatosis tumour-suppressor gene [J].
Bignell, GR ;
Warren, W ;
Seal, S ;
Takahashi, M ;
Rapley, E ;
Barfoot, R ;
Green, H ;
Brown, C ;
Biggs, PJ ;
Lakhani, SR ;
Jones, C ;
Hansen, J ;
Blair, E ;
Hofmann, B ;
Siebert, R ;
Turner, G ;
Evans, DG ;
Schrander-Stumpel, C ;
Beemer, FA ;
van den Ouweland, A ;
Halley, D ;
Delpech, B ;
Cleveland, MG ;
Leigh, I ;
Leisti, J ;
Rasmussen, S ;
Wallace, MR ;
Fenske, C ;
Banerjee, P ;
Oiso, N ;
Chaggar, R ;
Merrett, S ;
Leonard, N ;
Huber, M ;
Hohl, D ;
Chapman, P ;
Burn, J ;
Swift, S ;
Smith, A ;
Ashworth, A ;
Stratton, MR .
NATURE GENETICS, 2000, 25 (02) :160-165
[3]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[4]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[5]   RIG-I: tri-ing to discriminate between self and non-self RNA [J].
Bowie, Andrew G. ;
Fitzgerald, Katherine A. .
TRENDS IN IMMUNOLOGY, 2007, 28 (04) :147-150
[6]   Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[7]   Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 [J].
Häcker, H ;
Redecke, V ;
Blagoev, B ;
Kratchmarova, I ;
Hsu, LC ;
Wang, GG ;
Kamps, MP ;
Raz, E ;
Wagner, H ;
Häcker, G ;
Mann, M ;
Karin, M .
NATURE, 2006, 439 (7073) :204-207
[8]   Rescue of TRAF3-null mice by p100 NF-κB deficiency [J].
He, Jeannie Q. ;
Zarnegar, Brian ;
Oganesyan, Gagik ;
Saha, Supriya K. ;
Yamazaki, Soh ;
Doyle, Sean E. ;
Dempsey, Paul W. ;
Cheng, Genhong .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (11) :2413-2418
[9]   Ubiquitin-binding domains [J].
Hicke, L ;
Schubert, HL ;
Hill, CP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) :610-621
[10]   Triggering the innate antiviral response through IRF-3 activation [J].
Hiscott, John .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (21) :15325-15329